ArticleWorld journal of gastroenterology2023

Dihydroergotamine ameliorates liver fibrosis by targeting transforming growth factor β type II receptor.

Ke-Xin Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.